Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal Buprenorphine for Post-operative Pain After Ankle Fracture Surgery
NCT06949826Phase 4Recruiting
- Start
- Apr 2025
- Primary completion
- Mar 2027
- Modality
- Orthosteric Ligands, Inhalation Devices
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of v1003 in postoperative pain (2 arms). Primary endpoint: Morphine Milligram Equivalents of Full-agonist Opioid Consumed at 3 weeks. Started Apr 2025; status: recruiting.
02
Drugs
v1003
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06949826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06949826.